Wegovy may have highest ‘eye stroke’ and sight loss risk of semaglutide GLP-1 agonists. The risk is almost 5 times higher with Wegovy than it is with Ozempic, and 3 times greater in men than it is in women.
· 朱文 · 来源:tutorial频道
针对Wegovy may have highest ‘eye stroke’ and sight loss risk of semaglutide GLP-1 agonists. The risk is almost 5 times higher with Wegovy than it is with Ozempic, and 3 times greater in men than it is in women.的相关问题,本平台特邀行业资深人士进行深度解析与点评。